- Home
- ECPG vs SBFM Comparison
ECPG vs SBFM Comparison
Compare ECPG & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ECPG | SBFM |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 7.2M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | ECPG | SBFM |
|---|---|---|
| Price | $54.53 | $1.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $61.67 | $7.00 |
| AVG Volume (30 Days) | ★ 282.5K | 45.4K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,560,869,000.00 | $37,323,742.00 |
| Revenue This Year | $31.88 | $10.26 |
| Revenue Next Year | $3.57 | $32.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.52 | 13.24 |
| 52 Week Low | $26.45 | $1.17 |
| 52 Week High | $56.67 | $3.90 |
Technical Indicators
Market Signals| Indicator | ECPG | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 64.58 | 39.10 |
| Support Level | $53.02 | $1.35 |
| Resistance Level | $54.96 | $1.48 |
| Average True Range (ATR) | 1.59 | 0.07 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 56.40 | 27.78 |
Price Performance
Historical ComparisonAbout ECPG Encore Capital Group Inc
Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.